Cytek Biosciences, Inc. CTKB Inventory write-downs
Inventory write-downs at other companies
Other financials
Where this comes from
Reported directly by Cytek Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:InventoryWriteDown.
The official record: Cytek Biosciences, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cytek Biosciences, Inc.'s inventory write-downs.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cytek Biosciences, Inc.'s inventory write-downs?
- Cytek Biosciences, Inc. (CTKB) reported inventory write-downs of $193K in Q1 2026.
- How has Cytek Biosciences, Inc.'s inventory write-downs changed year-over-year?
- Cytek Biosciences, Inc.'s inventory write-downs decreased by 38.5% year-over-year, from $314K to $193K.
- What is the long-term trend for Cytek Biosciences, Inc.'s inventory write-downs?
- Over 3 years (2022 to 2025), Cytek Biosciences, Inc.'s inventory write-downs has grown at a 31.1% compound annual growth rate (CAGR), from $756K to $1.7M.
- What does inventory write-downs mean?
- Represents the non-cash charge taken to reduce the carrying value of inventory when its market value falls below cost due to obsolescence, damage, or declining demand. This metric serves as an indicator of inventory management efficiency and potential risks associated with product lifecycle transitions.